Detalhe da pesquisa
1.
Mechanisms and therapeutic implications of hypermutation in gliomas.
Nature
; 580(7804): 517-523, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32322066
2.
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Am J Hematol
; 98(4): 645-657, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36606708
3.
Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric study.
Support Care Cancer
; 30(12): 9841-9849, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36271944
4.
Patterns of progression in patients treated for immuno-oncology antibodies combination.
Cancer Immunol Immunother
; 70(1): 221-232, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32700090
5.
Phase 1 study of 2 high dose intensity schedules of the pan-Notch inhibitor crenigacestat (LY3039478) in combination with prednisone in patients with advanced or metastatic cancer.
Invest New Drugs
; 39(1): 193-201, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32915419
6.
Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review Paper.
Curr Oncol Rep
; 22(10): 98, 2020 07 28.
Artigo
Inglês
| MEDLINE | ID: mdl-32725503
7.
Clinical consideration for choosing combination therapies in advanced non-small-cell lung cancer: age, Eastern Cooperative Organization performance status 2, steroids and antibiotics.
Future Oncol
; 16(23): 1683-1690, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32479119
8.
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
Br J Cancer
; 119(8): 937-939, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30327567
9.
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials.
Invest New Drugs
; 36(1): 62-74, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28597151
10.
Prognostic factors and outcome of patients with hematological malignancies in phase I trials: the Gustave Roussy scoring system.
Anticancer Drugs
; 28(5): 540-545, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28225458
11.
Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.
Am J Hematol
; 96(10): E376-E379, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34165816
12.
Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1.
Ann Rheum Dis
; 78(7): e67, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29858173
13.
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review.
Eur J Cancer
; 205: 114075, 2024 May 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38733717
14.
Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations.
Cancer Treat Rev
; 127: 102751, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38729086
15.
Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer.
NEJM Evid
; 3(1): EVIDoa2300171, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38320513
16.
Antibody drug conjugates in older patients: State of the art.
Crit Rev Oncol Hematol
; 193: 104212, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38007063
17.
Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohort.
J Geriatr Oncol
; 14(2): 101423, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36657245
18.
Safety and efficacy of immunotherapy according to the age threshold of 80 years.
Bull Cancer
; 110(5): 570-580, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36894391
19.
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment.
Nutrients
; 15(5)2023 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36904192
20.
Prevalence of Four Sarcopenia Criteria in Older Patients with Cancer, and Their Predictive Value for 6-Month Mortality: The NutriAgeCancer National Prospective Cohort Study.
Nutrients
; 15(6)2023 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36986238